Qiagen Nv Stock Alpha and Beta Analysis
| QGEN Stock | USD 39.48 0.58 1.49% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Qiagen NV. It also helps investors analyze the systematic and unsystematic risks associated with investing in Qiagen NV over a specified time horizon. Remember, high Qiagen NV's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Qiagen NV's market risk premium analysis include:
Beta 0.24 | Alpha (0.13) | Risk 1.56 | Sharpe Ratio (0.14) | Expected Return (0.22) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Qiagen |
Qiagen NV Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Qiagen NV market risk premium is the additional return an investor will receive from holding Qiagen NV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Qiagen NV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Qiagen NV's performance over market.| α | -0.13 | β | 0.24 |
Qiagen NV expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Qiagen NV's Buy-and-hold return. Our buy-and-hold chart shows how Qiagen NV performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Qiagen NV Market Price Analysis
Market price analysis indicators help investors to evaluate how Qiagen NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Qiagen NV shares will generate the highest return on investment. By understating and applying Qiagen NV stock market price indicators, traders can identify Qiagen NV position entry and exit signals to maximize returns.
Qiagen NV Return and Market Media
The median price of Qiagen NV for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 44.35 with a coefficient of variation of 6.73. The daily time series for the period is distributed with a sample standard deviation of 2.89, arithmetic mean of 42.94, and mean deviation of 2.63. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Qiagen NV Announces Fourth Quarter 2024 Results Release and Conference Call | 01/15/2025 |
2 | Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now - Zacks Investment Research | 01/30/2025 |
3 | QIAGEN delivers solid Q4 2024 growth ahead of outlook | 02/05/2025 |
4 | Qiagen, Bio-Techne downgraded at Baird amid NIH funding concerns | 02/19/2025 |
5 | Europe Liquid Biopsy Market Analysis and Forecast 2024-2033, with Key Players Dxcover, F. Hoffmann-La Roche, GENinCode and Qiagen - ResearchAndMarkets.com | 02/20/2025 |
6 | Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, Bio-Techne, Qiagen, Helena Laboratories, Agilent Technologies, PerkinE... | 02/25/2025 |
7 | QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations ... | 03/03/2025 |
8 | Market is not liking Qiagens earnings decline as stock retreats 4.7 percent this week | 03/05/2025 |
9 | QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. ... | 03/06/2025 |
10 | Qiagen Receives Average Rating of Hold from Analysts | 03/07/2025 |
11 | Saudi Arabia Next Generation Sequencing Market Research 2025-2035 Key Players are Actively Advancing the Field Through Various Initiatives and Collaborations | 03/13/2025 |
About Qiagen NV Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Qiagen or other stocks. Alpha measures the amount that position in Qiagen NV has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 56.84 | 95.77 | 64.45 | 57.94 | PTB Ratio | 3.37 | 2.68 | 2.9 | 2.76 |
Qiagen NV Upcoming Company Events
As portrayed in its financial statements, the presentation of Qiagen NV's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Qiagen NV's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Qiagen NV's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Qiagen NV. Please utilize our Beneish M Score to check the likelihood of Qiagen NV's management manipulating its earnings.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Qiagen NV
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Qiagen NV Backtesting, Qiagen NV Valuation, Qiagen NV Correlation, Qiagen NV Hype Analysis, Qiagen NV Volatility, Qiagen NV History and analyze Qiagen NV Performance. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Qiagen NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.